Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (17649)
All Articles published online
|
Publishing Process of This Article
|
Jun 15, 2021 (publication date) through Mar 28, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Rojas M, Chávez-Castillo M, Bautista J, Ortega Á, Nava M, Salazar J, Díaz-Camargo E, Medina O, Rojas-Quintero J, Bermúdez V. Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links. World J Diabetes 2021; 12(6): 745-766 [PMID: 34168725 DOI: 10.4239/wjd.v12.i6.745] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Rojas M, Chávez-Castillo M, Bautista J, Ortega Á, Nava M, Salazar J, Díaz-Camargo E, Medina O, Rojas-Quintero J, Bermúdez V. Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links. World J Diabetes 2021; 12(6): 745-766 [PMID: 34168725 DOI: 10.4239/wjd.v12.i6.745] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v12/i6/745.htm |
| Number | Citing Articles |
| 1 |
Teresa Vezza, Víctor M Víctor. SIRT1 and miR-34a-5p: Valuable Biomarkers for the Early Detection of Cognitive Impairment in Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism 2024; 109(7): e1546 doi: 10.1210/clinem/dgad740
|
| 2 |
Cong Li, Haifeng Qian, Lina Feng, Mingquan Li. Causal Association Between Type 2 Diabetes Mellitus and Alzheimer’s Disease: A Two-Sample Mendelian Randomization Study. Journal of Alzheimer's Disease Reports 2024; 8(1): 945 doi: 10.3233/ADR-240053
|
| 3 |
Fan Zhang, Melissa Petersen, Leigh Johnson, James Hall, Sid E. O’Bryant. Comorbidities Incorporated to Improve Prediction for Prevalent Mild Cognitive Impairment and Alzheimer’s Disease in the HABS-HD Study. Journal of Alzheimer's Disease 2023; 96(4): 1529 doi: 10.3233/JAD-230755
|
| 4 |
Albert Joseph Sulangi, Sarah E Lyons, Amy A Abdou, Hemangi Patel, Deepika Nagliya, Eileen Joseph, Carmel Joseph, Divya Kumar, Shivani Patel, Isha Jinwala, Mayur S Parmar. Exploring the Therapeutic Potential of DPP4 Inhibitors in Alzheimer's Disease: Molecular Insight and Clinical Outcome. Cureus 2024; doi: 10.7759/cureus.72648
|
| 5 |
Ishitha Reddy, Chinmoy Sankar Dey. Purinergic signaling by ATP induces exercise‐like effects and ameliorates insulin resistance in HT22 mouse hippocampal cells. FEBS Letters 2025; 599(21): 3066 doi: 10.1002/1873-3468.70158
|
| 6 |
Ides M Colin, Lidia W Szczepanski, Anne-Catherine Gérard, Jose-Antonio Elosegi. Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer’s Disease. European Endocrinology 2023; 19(1): 16 doi: 10.17925/EE.2023.19.1.16
|
| 7 |
Mateusz Kciuk, Weronika Kruczkowska, Julia Gałęziewska, Katarzyna Wanke, Żaneta Kałuzińska-Kołat, Marta Aleksandrowicz, Renata Kontek. Alzheimer’s Disease as Type 3 Diabetes: Understanding the Link and Implications. International Journal of Molecular Sciences 2024; 25(22): 11955 doi: 10.3390/ijms252211955
|
| 8 |
Keke Song, Rongrong Zhang, Xiaoqi Zhao, Lan Yang, Qiang Wang, Wei Gao. Perioperative neurocognitive disorder changes in elderly diabetes patients within 30 days after surgery: a retrospective cohort study. Aging Clinical and Experimental Research 2023; 35(12): 2911 doi: 10.1007/s40520-023-02583-9
|
| 9 |
Sama Ayoub, Maryam Arabi, Yousef Al-Najjar, Ibrahim Laswi, Tiago F. Outeiro, Ali Chaari. Glycation in Alzheimer’s Disease and Type 2 Diabetes: The Prospect of Dual Drug Approaches for Therapeutic Interventions. Molecular Neurobiology 2025; 62(11): 14859 doi: 10.1007/s12035-025-05051-9
|
| 10 |
Insulin resistance and cognitive decline: the metabolic mechanisms linking type 2 diabetes to Alzheimer’s disease. Diabetology International 2025; 16(4): 614 doi: 10.1007/s13340-025-00830-0
|
| 11 |
Khaled Hameed Husain, Saud Faisal Sarhan, Haya Khaled Ali Abdulla AlKhalifa, Asal Buhasan, Abu Saleh Md Moin, Alexandra E. Butler. Dementia in Diabetes: The Role of Hypoglycemia. International Journal of Molecular Sciences 2023; 24(12): 9846 doi: 10.3390/ijms24129846
|
| 12 |
Monika Pliszka, Leszek Szablewski. Insulin Signaling in Alzheimer’s Disease: Association with Brain Insulin Resistance. International Journal of Molecular Sciences 2026; 27(3): 1222 doi: 10.3390/ijms27031222
|
| 13 |
Sarah Delforge, Catherine Hans, Aurélie Lupant. Le diabète de type 3 existe-t-il ? Les liens entre la maladie d’Alzheimer et le diabète de type 2. Médecine des Maladies Métaboliques 2026; doi: 10.1016/j.mmm.2026.02.007
|
| 14 |
Kayalvizhi Rajendran, Uma Maheswari Krishnan. Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease. Ageing Research Reviews 2024; 97: 102309 doi: 10.1016/j.arr.2024.102309
|
| 15 |
Jiwei Jiang, Hanping Shi, Shirui Jiang, Anxin Wang, Xinying Zou, Yanli Wang, Wenyi Li, Yuan Zhang, Mengfan Sun, Qiwei Ren, Jun Xu. Nutrition in Alzheimer’s disease: a review of an underappreciated pathophysiological mechanism. Science China Life Sciences 2023; 66(10): 2257 doi: 10.1007/s11427-022-2276-6
|
| 16 |
Osmar Vieira Ramires Júnior, Gustavo Ricardo Krupp Prauchner, Alessandra Schmitt Rieder, Ana Karla Oliveira Leite, Clarissa Penha Farias, Angela T. S. Wyse. Uncovering Hyperhomocysteinemia: Global Risk Patterns and Molecular Disruption in Brain and Vascular Health. Journal of Neurochemistry 2025; 169(12) doi: 10.1111/jnc.70327
|
| 17 |
Leszek Szablewski. Associations Between Diabetes Mellitus and Neurodegenerative Diseases. International Journal of Molecular Sciences 2025; 26(2): 542 doi: 10.3390/ijms26020542
|
| 18 |
Hoda M. Moghazy, Nesreen G Abdelhaliem, Sherine Ahmed Mohammed, Asmaa Hassan, Amany Abdelrahman. Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model. Pflügers Archiv - European Journal of Physiology 2024; 476(5): 779 doi: 10.1007/s00424-024-02933-0
|
| 19 |
Peter S. Hamblin, Anthony W. Russell, Stella Talic, Sophia Zoungas. The growing range of complications of diabetes mellitus. Trends in Endocrinology & Metabolism 2025; 36(10): 943 doi: 10.1016/j.tem.2024.12.006
|
| 20 |
Jessica E.B.F. Lima, Natalia C.S. Moreira, Elza T. Sakamoto-Hojo. Mechanisms underlying the pathophysiology of type 2 diabetes: From risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2022; : 503437 doi: 10.1016/j.mrgentox.2021.503437
|
| 21 |
Enoc Mariano Cortés Malagón, Adolfo López Ornelas, Irlanda Olvera Gómez, José Bonilla Delgado. The Kynurenine Pathway, Aryl Hydrocarbon Receptor, and Alzheimer’s Disease. Brain Sciences 2024; 14(9): 950 doi: 10.3390/brainsci14090950
|
| 22 |
Renshi Li, Fengjie Zheng, Peichen Xu, Li Lv, Yapeng Mu, Xianghua Zhuang, Shihong Chen. Correlation of mild cognitive impairment with the thickness of retinal nerve fiber layer and serum indicators in type 2 diabetic patients. Frontiers in Endocrinology 2024; 14 doi: 10.3389/fendo.2023.1299206
|
| 23 |
Flavia Agata Cimini, Marzia Perluigi, Ilaria Barchetta, Maria Gisella Cavallo, Eugenio Barone. Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update. International Journal of Molecular Sciences 2022; 23(10): 5574 doi: 10.3390/ijms23105574
|
| 24 |
Sophia Nazir. Salivary biomarkers: The early diagnosis of Alzheimer's disease. AGING MEDICINE 2024; 7(2): 202 doi: 10.1002/agm2.12282
|
| 25 |
Feng Zhao, Hui Yang, Huamei Liu, Heming Yu, Yang Zhao. FGF21 restores metabolic function in Alzheimer’s disease via activation of PI3K/Akt signaling. Neurological Research 2026; 48(1): 119 doi: 10.1080/01616412.2025.2521721
|
| 26 |
Ting Li, Hong-xia Cao, Dan Ke. Type 2 Diabetes Mellitus Easily Develops into Alzheimer’s Disease via Hyperglycemia and Insulin Resistance. Current Medical Science 2021; 41(6): 1165 doi: 10.1007/s11596-021-2467-2
|
| 27 |
Ananya Shukla, Khushbhu Meena, Ashish Gupta, Rajat Sandhir. 1H NMR-Based Metabolomic Signatures in Rodent Models of Sporadic Alzheimer’s Disease and Metabolic Disorders. ACS Chemical Neuroscience 2024; 15(24): 4478 doi: 10.1021/acschemneuro.4c00510
|
| 28 |
Gemma García-Lluch, Anna Marseglia, Lucrecia Moreno Royo, Juan Pardo Albiach, Mar Garcia-Zamora, Miquel Baquero, Carmen Peña-Bautista, Lourdes Álvarez, Eric Westman, Consuelo Cháfer-Pericás. Associations between antidiabetic medications and cerebrospinal fluid biomarkers of Alzheimer's disease. Journal of Alzheimer’s Disease 2025; 103(3): 758 doi: 10.1177/13872877241304995
|
| 29 |
Norhamidar Ab-Hamid, Norsuhana Omar, Che Aishah Nazariah Ismail, Idris Long. Diabetes and cognitive decline: Challenges and future direction. World Journal of Diabetes 2023; 14(6): 795-807 doi: 10.4239/wjd.v14.i6.795
Abstract(1165) |
Core Tip(807) |
Full Article(HTML)(4066)
|
Full Article with Cover (PDF)-1108K(201)
|
Full Article (Word)-469K(27)
|
Audio-295K(16)
|
Peer-Review Report-216K(142)
|
Answering Reviewers-109K(158)
|
Full Article (PDF)-902K(300)
|
Full Article (XML)-171K(164)
|
Times Cited (33)
|
Total Visits (10010)
|
Open
|
| 30 |
Sodiq Fakorede, Toheeb Ayodeji Sodiq, Abayomi Oyeyemi Ajagbe, Adewale James Adeleke, Okeoghene Marcel Edafetanure-Ibeh, Taiwo Ayomide Awobona, Abdullahi Tunde Aborode. Interplay of Glut1 alteration and Alzheimer's disease: A narrative review on glucose transport and energy metabolism. Journal of Alzheimer’s Disease 2025; 108(2): 470 doi: 10.1177/13872877251377793
|
| 31 |
Tanya Gupta, Shivam Kumar, Thakur Gurjeet Singh, Randhir Singh. The metabolic roots of memory loss: interlinking the Diabetes-Alzheimer’s hypothesis. Metabolic Brain Disease 2026; 41(1) doi: 10.1007/s11011-026-01824-w
|
| 32 |
Nilima S. Bangar, Anand Ganapathy A, Khalid M. Al-Anazi, Mohammad A. Farah, Waleed A. Q. Hailan, Andrej Frolov, Bishnudeo Roy, Anuradha Vaidya, Alaganandam Kumaran, Rashmi S. Tupe. Unravelling Anti-Glycation, Anti-Amyloid, Anti-Inflammatory, and Antioxidant Properties of Selected Medicinal Plant Extracts: A Multifaceted Novel Anti-Aging Approach. Natural Product Communications 2025; 20(8) doi: 10.1177/1934578X251363375
|
| 33 |
Si Han, Tom Lelieveldt, Miriam Sturkenboom, Geert Jan Biessels, Fariba Ahmadizar. Evaluating the Causal Association Between Type 2 Diabetes and Alzheimer’s Disease: A Two-Sample Mendelian Randomization Study. Biomedicines 2025; 13(5): 1095 doi: 10.3390/biomedicines13051095
|
| 34 |
Zheng Shen, Zheng-Yang Li, Meng-Ting Yu, Kai-Leng Tan, Si Chen. Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains. Biomedicine & Pharmacotherapy 2023; 158: 114206 doi: 10.1016/j.biopha.2022.114206
|
| 35 |
Yanchun Li, Zhongyang Lu, Cameron L. Kirkwood, Keith L. Kirkwood, Stephen A. Wank, Ai‐Jun Li, Maria F. Lopes‐Virella, Yan Huang. GPR40 deficiency worsens metabolic syndrome‐associated periodontitis in mice. Journal of Periodontal Research 2023; 58(3): 575 doi: 10.1111/jre.13107
|
| 36 |
Geetika Nehra, Bjoern Bauer, Anika M.S. Hartz. Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance. Pharmacology & Therapeutics 2022; 234: 108119 doi: 10.1016/j.pharmthera.2022.108119
|
| 37 |
Faiza Siddiqui, Pooja Mishra, Sheeba Khanam, Sachin Ranjan, Pravej Alam, Thamer Albalawi, Salman Khan, Snober S. Mir. Nano‐Chaperones: Bridging Therapeutics for Amyloid Aggregation in Alzheimer's Disease and Type‐2 Diabetes Mellitus. European Journal of Neuroscience 2025; 61(10) doi: 10.1111/ejn.70142
|
| 38 |
Cézar Augusto Alves de Oliveira, Bernardo Scaldini Oliveira, Amanda Scaldini Oliveira, Rafael Duarte de Souza Loduca, Carlos Roberto Massella Junior, Gabriel Silva Santos. Orthobiologics and Peptide Therapy for Central Nervous System Repair in Neurodegenerative Conditions. Cells 2025; 14(23): 1853 doi: 10.3390/cells14231853
|
| 39 |
Tatiana Korolenko, Nina Dubrovina, Marina Ovsyukova, Nataliya Bgatova, Michael Tenditnik, Alexander Pupyshev, Anna Akopyan, Natalya Goncharova, Chih-Li Lin, Evgeny Zavjalov, Maria Tikhonova, Tamara Amstislavskaya. Treatment with Autophagy Inducer Trehalose Alleviates Memory and Behavioral Impairments and Neuroinflammatory Brain Processes in db/db Mice. Cells 2021; 10(10): 2557 doi: 10.3390/cells10102557
|
| 40 |
Haiyang Du, Xiaoyu Meng, Yu Yao, Jun Xu. The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1033479
|
| 41 |
Rima Pramanik, Anuradha Dey, Anirban Kr Chakrabarty, Dipankar Banerjee, Avinash Narwaria, Swapnil Sharma, Rajiva Kumar Rai, Chandra Kant Katiyar, Sunil Kumar Dubey. Diabetes mellitus and Alzheimer's disease: Understanding disease mechanisms, their correlation, and promising dual activity of selected herbs. Journal of Ethnopharmacology 2024; 333: 118402 doi: 10.1016/j.jep.2024.118402
|
| 42 |
Richard Simon Machado, Khiany Mathias, Larissa Joaquim, Rafaella Willig de Quadros, Fabricia Petronilho, Gislaine Tezza Rezin. From diabetic hyperglycemia to cerebrovascular Damage: A narrative review. Brain Research 2023; 1821: 148611 doi: 10.1016/j.brainres.2023.148611
|
| 43 |
Nagwa M. Abdelazeem, Wael M. Aboulthana, Ashraf S. Hassan, Abdulrahman A. Almehizia, Ahmed M. Naglah, Hamad M. Alkahtani. Synthesis, in silico ADMET prediction analysis, and pharmacological evaluation of sulfonamide derivatives tethered with pyrazole or pyridine as anti-diabetic and anti-Alzheimer's agents. Saudi Pharmaceutical Journal 2024; 32(5): 102025 doi: 10.1016/j.jsps.2024.102025
|
| 44 |
Elizabeth M. Rhea, Manon Leclerc, Hussein N. Yassine, Ana W. Capuano, Han Tong, Vladislav A. Petyuk, Shannon L. Macauley, Xavier Fioramonti, Owen Carmichael, Frederic Calon, Zoe Arvanitakis. State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s Disease. Aging and disease 2023; : 0 doi: 10.14336/AD.2023.0814
|
| 45 |
Toshiyuki Oshitari. Advanced Glycation End-Products and Diabetic Neuropathy of the Retina. International Journal of Molecular Sciences 2023; 24(3): 2927 doi: 10.3390/ijms24032927
|
| 46 |
Aditi Singh, Sucharita Shadangi, Pulkit Kr. Gupta, Soumendra Rana. Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies. Comprehensive Physiology 2025; 15(1) doi: 10.1002/cph4.70003
|
| 47 |
Xin Yuan, Fei Yan, Li‐Hui Gao, Qian‐Hui Ma, Ju Wang. Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioning. CNS Neuroscience & Therapeutics 2023; 29(11): 3307 doi: 10.1111/cns.14260
|
| 48 |
Asmaa Embaby Sewillam, Zahra M Hasan Sry, Naguib A Salem, Ayat Allah Farouk Ahmed Hussein, Ahmed Essmat, Heba Ahmed Ali Abdeen. Effect of structured physical therapy program on patients with diabetes and mild cognitive impairment: randomised controlled trial. Physiotherapy Quarterly 2024; 32(2): 100 doi: 10.5114/pq/166622
|
| 49 |
Guglielmina Froldi. View on Metformin: Antidiabetic and Pleiotropic Effects, Pharmacokinetics, Side Effects, and Sex-Related Differences. Pharmaceuticals 2024; 17(4): 478 doi: 10.3390/ph17040478
|
| 50 |
Keiko Shigemori, Sachiko Nomura, Tomohiro Umeda, Shuko Takeda, Takami Tomiyama. Peripheral Aβ acts as a negative modulator of insulin secretion. Proceedings of the National Academy of Sciences 2022; 119(12) doi: 10.1073/pnas.2117723119
|
| 51 |
Shayan Yaghmayee, Atefeh Sadat Moazzeni, Tannaz Jamialahmadi, Sercan Karav, Habib Yaribeygi, Prashant Kesharwani, Amirhossein Sahebkar. Neuroprotective and cognitive benefits of Semaglutide: Insights into the underlying molecular mechanisms. Neuroscience 2025; 579: 187 doi: 10.1016/j.neuroscience.2025.06.009
|
| 52 |
Athena Enderami, Behnam Shariati, Mehran Zarghami, Aily Aliasgharian, Mobin Ghazaiean, Hadi Darvishi‐Khezri. Metformin and Cognitive Performance in Patients With Type 2 Diabetes: An Umbrella Review. Neuropsychopharmacology Reports 2025; 45(1) doi: 10.1002/npr2.12528
|
| 53 |
Oluwafemi Adeleke Ojo, Tobiloba Christiana Maduakolam-Aniobi, Gideon Ampoma Gyebi, Tenifayo Oluwatamilore Soyinka, Obianuju Favour Ejiogu, Adebola Busola Ojo, Mubarak Alruwaili, Naif H. Ali, Saud A. Alnaaim, Bshra A. Alsfouk, Gaber El-Saber Batiha. Experimental and computational analyses of the anti-alzheimer and antidiabetic effects of flavonoid-rich extract of avocado seeds (Persea americana Mill.). Nutrire 2025; 50(1) doi: 10.1186/s41110-025-00335-5
|
| 54 |
Nathan R. Kerr, Chandler W. Mossman, Chih-Hsuan Chou, Joshua M. Bunten, Taylor J. Kelty, Thomas E. Childs, Randy Scott Rector, William David Arnold, Laurel A. Grisanti, Xiangwei Du, Frank W. Booth. Hindlimb immobilization induces insulin resistance and elevates mitochondrial ROS production in the hippocampus of female rats. Journal of Applied Physiology 2024; 137(3): 512 doi: 10.1152/japplphysiol.00234.2024
|
| 55 |
Anne Grosskopf, Jette Rahn, Ahyoung Kim, Gábor Szabó, Dan Rujescu, Frank Klawonn, Andrej Frolov, Andreas Simm. Peptide-Bound Glycative, AGE and Oxidative Modifications as Biomarkers for the Diagnosis of Alzheimer’s Disease—A Feasibility Study. Biomedicines 2024; 12(9): 2127 doi: 10.3390/biomedicines12092127
|
| 56 |
Sweta Priyadarshini Pradhan, Anindita Behera, Pratap Kumar Sahu. Effect of selenium nanoparticles conjugated Vildagliptin on cognitive dysfunction associated with Diabetes mellitus. Journal of Drug Delivery Science and Technology 2024; 98: 105907 doi: 10.1016/j.jddst.2024.105907
|
| 57 |
Laryssa Alves-Borba, Verónica Espinosa-Fernández, Ania Canseco-Rodríguez, Ana María Sánchez-Pérez. ABA Supplementation Rescues IRS2 and BDNF mRNA Levels in a Triple-Transgenic Mice Model of Alzheimer’s Disease. Journal of Alzheimer's Disease Reports 2023; 7(1): 1007 doi: 10.3233/ADR-230056
|
| 58 |
Salsabila Khairunnisa, Koutatsu Maruyama, Saori Miyazaki, Isao Saito, Kiyohide Tomooka, Takeshi Tanigawa, Eri Eguchi, Tamami Shiba, Akiko Kooka, Kazumi Fujimura, Keiko Suyama, Ryoichi Kawamura, Yasunori Takata, Haruhiko Osawa. The Association Between Dietary Fat Intake and Mild Cognitive Impairment in Japanese Men and Women: The Toon Health Study. Dietetics 2025; 4(4): 43 doi: 10.3390/dietetics4040043
|
| 59 |
Saptadip Samanta. Diabetes and Neurodegeneration. 2026; : 45 doi: 10.1016/B978-0-443-33355-2.00029-3
|
| 60 |
Ana Silva, Sónia Silva, Beatriz Rodrigues, Gonçalo Simões, Inês Dinis, Mafalda Freitas, Rosa Resende, Joana Bicker, Ana Fortuna, Maria M. Silva, Armanda E. Santos, Sónia A. Pinho, Bruno Neves, Cláudia Fragão Pereira, Maria Teresa Cruz, Sandra Moreno. Targeting NRF2 With Isoeugenol: A Promising Small Molecule for Neurodegenerative, Metabolic, and Chronic Inflammatory Disorders. Oxidative Medicine and Cellular Longevity 2025; 2025(1) doi: 10.1155/omcl/7695056
|
| 61 |
Yashika Arora, Anirban Dutta. Perspective: Disentangling the effects of tES on neurovascular unit. Frontiers in Neurology 2023; 13 doi: 10.3389/fneur.2022.1038700
|
| 62 |
Demos Kynigopoulos, Eleni Fella, Lucy Shahabian, Christiana C. Christodoulou, Revekka Papacharalampous, Konstantinos Diskos, Lida Evmorfia Vagiaki, Kyriaki Sidiropoulou, Menelaos Pipis, Kleopas A. Kleopa, Elena Panayiotou. Systemic lipid and glucose modulation differentially affects cognitive function and neuroinflammation in a mouse model of Alzheimer’s disease. Frontiers in Neuroscience 2025; 19 doi: 10.3389/fnins.2025.1636624
|
| 63 |
Lívia C. R. Teixeira, Marcelo R. Luizon, Karina B. Gomes. Exploring the Role of GLP-1 Receptor Agonists in Alzheimer’s Disease: A Review of Preclinical and Clinical Evidence. Receptors 2025; 4(1): 2 doi: 10.3390/receptors4010002
|
| 64 |
Xuan Ren, Gaobo Zhang, Boqian Zhou, Wenting Gu, Qiuchen Zhu, Xin Liu. Cerebrovascular mechanisms between type 2 diabetes and Alzheimer's disease: Insights from ultrasound localization microscopy. Medical Physics 2025; 52(11) doi: 10.1002/mp.70131
|
| 65 |
Ana Knezovic, Melita Salkovic-Petrisic. Cholinergic neurotransmission in the brain of streptozotocin-induced rat model of sporadic Alzheimer’s disease: long-term follow up. Journal of Neural Transmission 2025; 132(10): 1461 doi: 10.1007/s00702-025-02887-2
|
| 66 |
Xin Liu, Keke Che, Qiaoli Li, Xiuli Wu, Dong Zeng, Xiaoli Du, Shanglan Qing. Porphyromonas gingivalis promotes the formation and development of type 2 diabetes mellitus complicated with cognitive impairment by regulating gut microbiota and metabolic pathways. Molecular Medicine 2025; 31(1) doi: 10.1186/s10020-025-01342-y
|
| 67 |
Jiehui Chen, Yong Liu, Keru Zhou, Wei Zhang, Bin Wen, Kai Xu, Yazhou Liu, Ling Chen, Yue Huang, Benhong He, Weijian Hang, Juan Chen. DISC1 inhibits GSK3β activity to prevent tau hyperphosphorylation under diabetic encephalopathy. BioFactors 2023; 49(1): 173 doi: 10.1002/biof.1884
|
| 68 |
Ozra Tabatabaei Malazy, Fatemeh Bandarian, Mostafa Qorbani, Shahrzad Mohseni, Somayeh Mirsadeghi, Maryam Peimani, Bagher Larijani. The effect of metformin on cognitive function: A systematic review and meta-analysis. Journal of Psychopharmacology 2022; 36(6): 666 doi: 10.1177/02698811211057304
|
| 69 |
LaQuadria S. Robinson, Kristin D. Ashley, Tiffany Brown Ervin, Tina Smith, Loretta T. Lee. A Narrative Review of Alzheimer Dementia in African American and Hispanic Populations: The Health Care Provider's Role. The Journal for Nurse Practitioners 2024; 20(8): 105104 doi: 10.1016/j.nurpra.2024.105104
|
| 70 |
Afrooz Anbaraki, Atiyeh Ghasemi, Arefeh Seyedarabi, Reza Yousefi, Ali Akbar Saboury. Dual glycation and oxidation of tau protein: impact of methylglyoxal and hydrogen peroxide on tau structure and fibril assembly. Free Radical Biology and Medicine 2026; 243: 207 doi: 10.1016/j.freeradbiomed.2025.11.044
|
| 71 |
Edric D. Winford, Ryan Shahidehpour, Dallin Dressman, Jadwiga Turchan-Cholewo, Katherine M. Cotter, Noah Leibold, Thomas A. Ujas, Daimen R.S. Britsch, Domenico Mercurio, Mary K. Colson, Nirmal Verma, Sanda Despa, Adam D. Bachstetter, Florin Despa, Ann M. Stowe. Pancreatic hypersecretion of amyloid-forming human amylin dysregulates the neuro-immune axis and B cell development in a model of type-2 diabetes. Neurobiology of Disease 2025; 216: 107153 doi: 10.1016/j.nbd.2025.107153
|
| 72 |
Xian-wen Ye, Meng-nan Liu, Xuan Wang, Shui-qing Cheng, Chun-shuai Li, Yu-ying Bai, Lin-lin Yang, Xu-xing Wang, Jia Wen, Wen-juan Xu, Shu-yan Zhang, Xin-fang Xu, Xiang-ri Li. Exploring the common pathogenesis of Alzheimer’s disease and type 2 diabetes mellitus via microarray data analysis. Frontiers in Aging Neuroscience 2023; 15 doi: 10.3389/fnagi.2023.1071391
|